Cytosorbents (CTSO) Earnings Date & Reports

CytoSorbents Corp is a leader in blood purification for the treatment of life-threatening conditions in the intensive care unit and cardiac surgery... Show more

Industry: #Medical Specialties

Get AI intraday signals

A.I. Advisor

published Earnings

CTSO is expected to report earnings to fall 17.40% to -4 cents per share on August 04

Cytosorbents CTSO Stock Earnings Reports

Q2'26

Est.

$-0.04

Q1'26

Missed

by $0.01

Q4'25

Missed

by $0.03

Q3'25

Beat

by $0.01

Q2'25

Missed

by $0.01

The last earnings report on May 13 showed earnings per share of -5 cents, missing the estimate of -3 cents. With 194.65K shares outstanding, the current market capitalization sits at 29.95M.

View a ticker or compare two or three

Compare

CTSO

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for CTSO